Search results
- 1.0542556 - ÚOCHB 2022 RIV CH eng J - Journal Article
Fürst, R. - Fürst, Eliška - Vlach, T. - Řepka, J. - Pokorný, M. - Mózer, V.
Use of Cement Suspension as an Alternative Matrix Material for Textile-Reinforced Concrete.
Materials. Roč. 14, č. 9 (2021), č. článku 2127. E-ISSN 1996-1944
Institutional support: RVO:61388963
Keywords : textile-reinforced concrete * non-combustibility * cohesion * high-performance concrete * carbon fibers * cement matrix
OECD category: Materials engineering
Impact factor: 3.748, year: 2021
Method of publishing: Open access
https://doi.org/10.3390/ma14092127
Permanent Link: http://hdl.handle.net/11104/0319942 - 2.0505516 - ÚEB 2020 RIV US eng J - Journal Article
Rárová, L. - Ncube, B. - Van Staden, J. - Fürst, R. - Strnad, Miroslav - Grúz, Jiří
Identification of Narciclasine as an in Vitro Anti-Inflammatory Component of Cyrtanthus contractus by Correlation-Based Metabolomics.
Journal of Natural Products. Roč. 82, č. 5 (2019), s. 1372-1376. ISSN 0163-3864. E-ISSN 1520-6025
Institutional support: RVO:61389030
Keywords : amaryllidaceae * anti-Inflammatory Component * nanotechnology * gene engineering
OECD category: Organic chemistry
Impact factor: 3.782, year: 2019
Method of publishing: Open access
http://doi.org/10.1021/acs.jnatprod.8b00973
Permanent Link: http://hdl.handle.net/11104/0296997File Download Size Commentary Version Access 2019_Rarova_JOURNAL OF NATURAL PRODUCTS_1372.pdf 0 2.1 MB Other open-access - 3.0382222 - ÚEB 2013 RIV GB eng J - Journal Article
Kryštof, Vladimír - Baumli, S. - Fürst, R.
Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target.
Current Pharmaceutical Design. Roč. 18, č. 20 (2012), s. 2883-2890. ISSN 1381-6128. E-ISSN 1873-4286
R&D Projects: GA ČR GAP305/12/0783
Institutional research plan: CEZ:AV0Z50380511
Keywords : Cancer * inflammation * kinase
Subject RIV: ED - Physiology
Impact factor: 3.311, year: 2012
http://www.benthamdirect.org/pages/article/1/3177374/perspective-of-cyclin-dependent-kinase-9-cdk9-as-a-drug-target.html
Permanent Link: http://hdl.handle.net/11104/0212510File Download Size Commentary Version Access 2012_Krystof_CURRENT PHARMACEUTICAL DESIGN_2883.pdf 0 240.4 KB Other open-access